sales@businessmarketinsights.com     UK: +442081254005
   

North America Chronic Cough Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class (Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, and Other Drug Class); Route of Administration (Oral, Injections, Inhalation, and Other Route of Administration); Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy); and Country

Code: TIPRE00013291 | Pages: 97 | Industry: Pharmaceuticals | Date: Aug 2020
Covid

Market Introduction

Chronic cough is defined as a persistent cough that lasts long up to 6-8 weeks. It significantly affects the patients' lives by interrupting sleeping, vomiting, light-headedness, and even rib fractures. It is caused due to multiple reasons such as infections, asthma, gastroesophageal reflux disease (GERD), among others.

Market Overview and Dynamics

The North America Chronic Cough market is projected to reach US$ 3,944.89 million by 2027 from US$ 2,118.42 million in 2019; it is estimated to grow with a CAGR of 8.1% from 2020 to 2027. The growth of the North America chronic cough market is attributed to the rising incidences of chronic cough, growing product developments to treat chronic cough. However, product recalls limits the growth of market in this region. Countries in Asia Pacific are expecting to witness huge challenge due to growing COVID-19. Due to outbreak of disease, healthcare industries has been affected badly. Due to growing coronavirus cases, many business related activities such as product launches and product promotion conferences has been postponed, leading to restraining the growth of the market.

Key Market Segments

Based on drug class, the North America Chronic Cough market is segmented into antihistamines, corticosteroids, decongestants, combination drug, antibiotics, acid blockers, and other drug class. In 2019, the combination drug segment held a larger share of the market. And is expected to grow at a faster rate during the forecast period.

Major Sources and Companies Listed

A few major primary and secondary sources referred to while preparing the North America Chronic Cough Market report are World Health Organization, Ministry of Health and Prevention, and Ministry of Health and Family Welfare.

Novartis AG, Teva Pharmaceutical Industries Ltd, GlaxoSmithKline plc., Bayer AG, Mylan N.V., Amneal Pharmaceuticals, Inc., Cipla Inc., Reckitt Benckiser Group plc., Sun Pharmaceutical Industries Ltd, and Aurobindo Pharma Ltd.

 

Reasons to buy the report

  • To understand the North America chronic cough market landscape and identify market segments that are most likely to guarantee a strong return
  • To stay ahead in comprehending the ever-changing competitive landscape of the North America Chronic Cough market
  • To efficiently plan M&A and partnership deals in the North America chronic cough market by identifying market segments with the most promising probable sales
  • To help take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments in the North America chronic cough market
  • To obtain market revenue forecast from 2019 to 2027 in various segments of the North America chronic cough market

NORTH AMRICA CHRONIC COUGH MARKET SEGMENTATION

By Drug Class

  • Antihistamines
  • Corticosteroids
  • Decongestants
  • Combination Drug
  • Antibiotics
  • Acid Blockers
  • Other Drug Class

By Route of Administration

  • Oral
  • Injections
  • Nasal
  • Other Route of Administration

 

By Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

By Country

  • US
  • Canada
  • Mexico

 

Company Profiles

  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc.
  • Bayer AG
  • Mylan N.V.
  • Amneal Pharmaceuticals, Inc.
  • Cipla Inc.
  • Reckitt Benckiser Group plc.
  • Sun Pharmaceutical Industries Ltd
  • Aurobindo Pharma Ltd

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Chronic Cough Market – By Drug Class

1.3.2        Chronic Cough Market – By Route of Administration

1.3.3        Chronic Cough Market – By Distribution Channel

1.3.4        North America Chronic Cough Market – By Country

2.          Chronic Cough Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Chronic Cough Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Expert Opinion

5.          Chronic Cough Market – Key Market Dynamics

5.1        Market Drivers

5.1.1        Rising Incidences of Chronic Cough

5.1.2        Growing Product Developments to Treat Chronic Cough

5.2        Market Restraints

5.2.1        Product Recalls

5.3        Market Opportunities

5.3.1        Aging Population is Expected to Drive Demand for Chronic Cough Treatment

5.4        Future Trends

5.4.1        Continuous Trend of Drug Development

5.5        Impact Analysis

6.          Chronic Cough Market Analysis – By Drug Class

6.1        Overview

6.2        Chronic Cough Market Revenue Share, by Drug Class (2019 and 2027)

6.3        Antihistamines

6.3.1        Overview

6.3.2        Antihistamines: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.4        Corticosteroids

6.4.1        Overview

6.4.2        Corticosteroids: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.5        Decongestants

6.5.1        Overview

6.5.2        Decongestants: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.6        Combination Drug

6.6.1        Overview

6.6.2        Combination Drug: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.7        Antibiotics

6.7.1        Overview

6.7.2        Antibiotics: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.8        Acid Blockers

6.8.1        Overview

6.8.2        Acid Blockers: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.9        Other Drug Class

6.9.1        Overview

6.9.2        Other Drug Class: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.          Chronic Cough Market – By Route of Administration

7.1        Overview

7.2        Chronic Cough Market, by Route of Administration, 2019 and 2027 (%)

7.3        Oral

7.3.1        Overview

7.3.2        Oral: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.4        Injections

7.4.1        Overview

7.4.2        Injections: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.5        Inhalation

7.5.1        Overview

7.5.2        Inhalation: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.6        Other Route of Administration

7.6.1        Overview

7.6.2        Other Route of Administration: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

8.          Chronic Cough Market – By Distribution Channel

8.1        Overview

8.2        Chronic Cough Market, by Distribution Channel, 2019 and 2027 (%)

8.3        Hospital Pharmacy

8.3.1        Overview

8.3.2        Hospital Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

8.4        Online Pharmacy

8.4.1        Overview

8.4.2        Online Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

8.5        Retail Pharmacy

8.5.1        Overview

8.5.2        Retail Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

9.          Chronic Cough Market – Regional Analysis

9.1        North America Chronic Cough Market

9.1.1        Overview

9.1.2        North America: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        North America: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)

9.1.4        North America: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

9.1.5        North America: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

9.1.6        North America: Chronic Cough Market, by Country, 2019 & 2027 (%)

9.1.7        US: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          US: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          US: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)

9.1.7.3          US: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

9.1.7.4          US: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

9.1.8        Canada: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          Canada: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          Canada: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)

9.1.8.3          Canada: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

9.1.8.4          Canada: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

9.1.9        Mexico: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.1          Mexico: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.2          Mexico: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)

9.1.9.3          Mexico: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

9.1.9.4          Mexico: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

10.       Impact of COVID-19 Pandemic on North America Chronic cough Market

10.1      Impact Assessment of COVID-19 Pandemic

11.       COMPANY PROFILES

11.1      Novartis AG

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      TEVA PHARMACEUTICAL INDUSTRIES LTD

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      GlaxoSmithKline plc.

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Bayer AG

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      MYLAN N.V.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Amneal Pharmaceuticals, Inc.

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Cipla Inc.

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      Reckitt Benckiser Group plc.

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      Sun Pharmaceutical Industries Ltd

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10   Aurobindo Pharma Ltd

11.10.1   Key Facts

11.10.2   Business Description

11.10.3   Products and Services

11.10.4   Financial Overview

11.10.5   SWOT Analysis

11.10.6   Key Developments

12.       Appendix

12.1      Glossary of Terms

 

LIST OF TABLES

Table 1.            North America Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 2.            North America Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 3.            North America Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 4.            US Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 5.            US Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 6.            US Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 7.            Canada Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 8.            Canada Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 9.            Canada Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 10.          Mexico Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 11.          Mexico Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 12.          Mexico Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 13.          Glossary of Terms, Chronic Cough Market

 

LIST OF FIGURES

Figure 1.           Chronic Cough Market Segmentation

Figure 2.           Chronic Cough Market – By Geography

Figure 3.           North America Chronic Cough Market Overview

Figure 4.           Combination Drug Segment Held Largest Share of Chronic Cough Market

Figure 5.           US to Show Remarkable Growth During Forecast Period

Figure 6.           PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           Chronic Cough Market Impact Analysis of Drivers and Restraints

Figure 9.           Chronic Cough Market Revenue Share, by Drug Class (2019 and 2027)

Figure 10.        Antihistamines: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Corticosteroids: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Decongestants: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Combination Drug: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Antibiotics: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Acid Blockers: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Other Drug Class: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Chronic Cough Market, by Route of Administration, 2019 and 2027 (%)

Figure 18.        Oral: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Injections: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Inhalation: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Other Route of Administration: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Chronic Cough Market, by Distribution Channel, 2019 and 2027 (%)

Figure 23.        Hospital Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Online Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Retail Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        North America: Chronic Cough Market, by Key Country – Revenue (2019) (USD Million)

Figure 27.        North America Chronic Cough Market Revenue and Forecast to 2027 (USD Million)

Figure 28.        North America: Chronic Cough Market, by Country, 2019 & 2027 (%)

Figure 29.        US: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Canada: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        Mexico: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.        Impact of COVID-19 Pandemic in North American Country Markets

 

 

 

  1. Novartis AG
  2. Teva Pharmaceutical Industries Ltd
  3. GlaxoSmithKline plc.
  4. Bayer AG
  5. Mylan N.V.
  6. Amneal Pharmaceuticals, Inc.
  7. Cipla Inc.
  8. Reckitt Benckiser Group plc.
  9. Sun Pharmaceutical Industries Ltd
  10. Aurobindo Pharma Ltd
  • To understand the North America chronic cough market landscape and identify market segments that are most likely to guarantee a strong return
  • To stay ahead in comprehending the ever-changing competitive landscape of the North America Chronic Cough market
  • To efficiently plan M&A and partnership deals in the North America chronic cough market by identifying market segments with the most promising probable sales
  • To help take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments in the North America chronic cough market
  • To obtain market revenue forecast from 2019 to 2027 in various segments of the North America chronic cough market

Related Tags North America Chronic Cough Market North America Chronic Cough Market Research North America Chronic Cough Market Insight North America Chronic Cough Market Trends North America Chronic Cough Market Forecast North America Chronic Cough Market Share North America Chronic Cough Market 2027 North America Chronic Cough Market Growth North America Chronic Cough Market Industry Sector North America Chronic Cough Market PDF Report North America Chronic Cough Market Analysis North America Chronic Cough Market Research Competitive Analysis

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000